News
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...
The $7.8 million investment will fund further drug testing and development to advance its drug candidates to clinical trials.
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback